Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report

BACKGROUND: Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder considered to be a variant of multiple myeloma. It is an aggressive disease with a poor clinical response to standard chemotherapeutic agents. CASE PRESENTATION: A novel regimen consisting of bortezomib, doxorubicin, and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Steven M, George, Tracy, Cherry, Athena M, Medeiros, Bruno C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644294/
https://www.ncbi.nlm.nih.gov/pubmed/19192311
http://dx.doi.org/10.1186/1757-1626-2-121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644294/
https://www.ncbi.nlm.nih.gov/pubmed/19192311
http://dx.doi.org/10.1186/1757-1626-2-121

Ejemplares similares